The recurrent CNV events shared by gynecologic cancers are predicted to cause amplifications of retinal proteins FAM138D and FAM138E, and deletions of genes associated with IFN-α/β signaling, which can be viewed as a strategy of immune evasion. This evidence concerns the gene FAM138E and female reproductive organ cancer.